ARDELYX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ARDELYX, INC. (ARDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.78 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 766.00K shares, a 51.09% decline year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 1.01M shares, a 23.51% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 2.38M shares, a 301.69% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 1.47M shares, a 624.14% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 6.24M shares, a 465.64% increase from fiscal 2024.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.10M shares, a 128.36% increase from fiscal 2023.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 483.00K shares, a 73.64% decline from fiscal 2022.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.83M shares, a 25.26% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 766.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.78M shares 10-Q · filed 2026-08-06 | 4.16M shares derived: sum of 3 quarters · filed 2026-08-06 | 5.63M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.01M shares 10-Q · filed 2026-04-30 | 3.40M shares derived: sum of 2 quarters · filed 2026-04-30 | 4.87M shares derived: sum of 3 quarters · filed 2026-04-30 | 6.43M shares derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | 2.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 3.85M shares derived: sum of 2 quarters · filed 2026-02-19 | 5.42M shares derived: sum of 3 quarters · filed 2026-02-19 | 6.24M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 1.47M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | 3.04M shares derived: sum of 2 quarters · filed 2025-10-30 | 3.86M shares 10-Q · filed 2025-10-30 | 4.45M shares derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | 1.57M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 2.39M shares 10-Q · filed 2025-08-04 | 2.98M shares derived: sum of 3 quarters · filed 2025-08-04 | 3.18M shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 821.00K shares 10-Q · filed 2025-05-01 | 1.41M shares derived: sum of 2 quarters · filed 2025-05-01 | 1.62M shares derived: sum of 3 quarters · filed 2025-05-01 | 1.75M shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 593.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 796.00K shares derived: sum of 2 quarters · filed 2025-02-20 | 925.00K shares derived: sum of 3 quarters · filed 2025-02-20 | 1.10M shares 10-K · filed 2025-02-20 |
| 2024-09-30 | 203.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 332.00K shares derived: sum of 2 quarters · filed 2024-10-31 | 510.00K shares 10-Q · filed 2024-10-31 | 849.00K shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 129.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 307.00K shares 10-Q · filed 2024-08-01 | 646.00K shares derived: sum of 3 quarters · filed 2024-08-01 | 669.00K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 178.00K shares 10-Q · filed 2024-05-02 | 517.00K shares derived: sum of 2 quarters · filed 2024-05-02 | 540.00K shares derived: sum of 3 quarters · filed 2024-05-02 | 605.00K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 339.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 362.00K shares derived: sum of 2 quarters · filed 2024-02-22 | 427.00K shares derived: sum of 3 quarters · filed 2024-02-22 | 483.00K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 23.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 88.00K shares derived: sum of 2 quarters · filed 2023-10-31 | 144.00K shares 10-Q · filed 2023-10-31 | 522.00K shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 65.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 121.00K shares 10-Q · filed 2023-08-02 | 499.00K shares derived: sum of 3 quarters · filed 2023-08-02 | 763.00K shares derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | 56.00K shares 10-Q · filed 2023-05-03 | 434.00K shares derived: sum of 2 quarters · filed 2023-05-03 | 698.00K shares derived: sum of 3 quarters · filed 2023-05-03 | 882.00K shares derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | 378.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 642.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 826.00K shares derived: sum of 3 quarters · filed 2023-03-02 | 1.83M shares 10-K · filed 2023-03-02 |
| 2022-09-30 | 264.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 448.00K shares derived: sum of 2 quarters · filed 2022-11-03 | 1.45M shares 10-Q · filed 2022-11-03 | 2.42M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 184.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.19M shares 10-Q · filed 2022-08-04 | 2.16M shares derived: sum of 3 quarters · filed 2022-08-04 | 3.24M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 1.01M shares 10-Q · filed 2022-05-05 | 1.98M shares derived: sum of 2 quarters · filed 2022-05-05 | 3.06M shares derived: sum of 3 quarters · filed 2022-05-05 | |
| 2021-12-31 | 970.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 2.05M shares derived: sum of 2 quarters · filed 2022-02-28 | 2.45M shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 1.08M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 1.48M shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 401.00K shares 10-Q · filed 2021-08-13 | |||
| 2020-12-31 | 764.72K shares 10-K · filed 2021-03-08 | |||
| 2019-12-31 | 528.62K shares 10-K · filed 2020-03-06 | |||
| 2018-12-31 | 1.01M shares 10-K · filed 2019-03-06 | |||
| 2017-12-31 | 445.03K shares 10-K · filed 2019-03-06 | |||
| 2016-12-31 | 67.74K shares 10-K · filed 2019-03-06 | |||
| 2015-12-31 | 28.56K shares 10-K · filed 2018-03-14 | |||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | 2.22K shares derived: sum of 2 quarters · filed 2017-02-17 | 4.08K shares 10-K · filed 2017-02-17 | |
| 2014-09-30 | 2.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 4.08K shares 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | 1.86K shares 10-Q · filed 2014-08-08 | |||
| 2013-12-31 | 6.63K shares 10-K · filed 2016-03-04 | |||
| 2012-12-31 | 43.85K shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |